Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Um, that outstanding presentation that six people tuned in to ?
Pizza delivery for those late nights putting together the filings ?
Don't forget the window darkening shades so nobody can see that there is nothing going on inside .
GLTus >> M
A little movement here today . Release the Kraken , boss ...
Enjoy the weekend >> M
Good question . Some answers may be found in recent amended quarterly report :
https://www.otcmarkets.com/stock/CNHC/disclosure
Twitter me this ... The boss failed . But , THANKS for your patience ,, B S .
Should go current with attorney letter .
Let's get that quarterly filing in to OTC boys and girls .
You shouldn't be playing "catch up" all the time .
How hard could it be with NO revenue ??? Eh ?
VERY nice ...
Where are the FILINGS promised ? Runnin' out of time Brah ...
Just in time to avoid going EM we hope ...
And so are we .
New posters would do well to read previous posts before "sharing" .
Updated filings : https://www.otcmarkets.com/stock/SIPC/disclosure
Not getting any younger over here .... Where's the beef ???
Pretty sure this "trade" isn't retail ...
05/09/2023 13:51:07 EDT 0.00055 10,540,783
Probably a "cross" trade .... After "they" are done we move up , I HOPE ... LOL .
Definitely some shenanigans going on .. lots of selling pressure .
Which side will end up being "winners" ??? I have placed my bets ...
NP So , a possible scenario to consider >>
Not sure if OTC sends this to EM when the "grace period" expires but ...
$NAFS gets the filings current quickly this "should" recover .
I hope ... LOL .
GLTus >> M
"Verified Profile" is noted here now : https://www.otcmarkets.com/stock/NAFS/disclosure
So , 39 cents now .... Where's the bottom for this 7 dollar stock ??? Eh ?
Quarterly Report just posted : https://www.otcmarkets.com/stock/NAFS/disclosure
Now if they can get the Annual posted in time .......
If I may : HOPE is not a good investment strategy ....
So , falsely stating that a "BIG UPDATE COMING END OF WEEK " is OK ?
'Cause he's trying , right ?
$CSLI FILINGS are the ONLY thing that matters here and NOW ! ! ! CAPISCE ???
Having traded $SMURF from it's rally in the USD range of $2.50 to the present range of 10 cents ,
I have many observations / opinions .
1) COIN ( Tokens in Canada $SMURF in US ) has been and still is fiercely shorted .
2) ALL of these Canadian 5 lettered stocks have brutal algorithms running all day stepping in front of our trades . ALL of the offers displayed on L2 in front of your / my bid and ask are decoys .
That's why you see so much volume displayed on the bid and ask .
3) Metaverse was and still is WAY ahead of it's time . Even Zuckerberg will admit that .
4) $SMURF's CEO is a smart guy and the ONLY reason that I am reluctantly still here .
He and many others got caught with their pants down when crypto collapsed .
My advise is to take $SMURF off your watchlist ( if you can ) before it drives you crazy .
Drop to " Limited Info " if anyone cares : https://www.otcmarkets.com/stock/TNPH/disclosure
Oh looky , another S-1/A has been filed : https://www.otcmarkets.com/stock/WETH/disclosure
Company officers should be held accountable for their misleading tweets . ( lies )
$NAFS has entered into a " Grace Period " ... https://www.otcmarkets.com/stock/NAFS/disclosure
"This security has entered a Grace Period, where it can be publicly quoted for 15 days before moving to the Expert Market for unsolicited quoting only. Securities enter the Grace Period when OTC Markets Group is no longer able to confirm that the issuer’s disclosure is current and publicly available as required under Rule 15c2-11."
$CSLI has entered into < Grace Period > ... https://www.otcmarkets.com/stock/CSLI/disclosure
"This security has entered a Grace Period, where it can be publicly quoted for 15 days before moving to the Expert Market for unsolicited quoting only. Securities enter the Grace Period when OTC Markets Group is no longer able to confirm that the issuer’s disclosure is current and publicly available as required under Rule 15c2-11."
FILINGS !!!! Expert Market without them ... DUH .
Oh , I can relate , as I am stuck with some shares from that price range ...
I agree that someone paid for that PR with an agenda in mind .
$PBLA just had a 1:40 stock split Jan. 13 2023 .
Then they had a Public Offering in Feb. at $1.25 a share . THOSE guys must be pissed .
And $CSLI ???? Where the frig are the friggin' FILINGS , MAN ???????
Market isn't buying anything $WETH is putting out .... Something smells poopy .
Only 2 MMs representing bids ...
Both are no longer relevant .
(Apologies to phonebooth lovers out there , but really ?)
Where are the freekin' filings ???
The "elephant" in the room is causing some more concern I see ...
Typical OTC stinker ...
Hang in there . Gonna be fine .... NOT ! ! !
04/18/2023 14:25:06 EDT 0.00001 10000
Where are the promised filings ? Eh ?
https://www.otcmarkets.com/stock/CSLI/disclosure
Lurker here ... Nice bump today . This seems like good news to me ...
MOUNTAIN VIEW, Calif., April 18, 2023
Commercial agreement follows the early success on the development phase of the UDCA program with Sandhill One
Solid execution on development phases leads to execution of agreement; illustrates company progress against targeted milestones anticipated for 2023 to expand company growth
Willow's unique combination of strain engineering, precision fermentation and its newly developed BioOxiâ„¢ bio-oxidation platform has accelerated the timeline to reach commercial agreement
MOUNTAIN VIEW, Calif., April 18, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW); (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces execution of a commercial agreement with Sandhill One, LLC ("Sandhill"). Willow previously announced the successful results from the application of its BioOxiTM bio-oxidation platform to the development of a key step for the large volume active pharmaceutical ingredient ("API"), ursodeoxycholic acid ("UDCA"), used in nutraceutical and pharmaceutical products.
Willow Biosciences Inc. Logo (CNW Group/Willow Biosciences Inc.)
UDCA is used as a medication for the management and treatment of cholestatic liver disease and gallstone conditions, and as an important intermediate for production of tauroursodeoxycholic acid (TUDCA), a key API in a combination therapy recently approved in Canada and the United States for treatment of amyotrophic lateral sclerosis (ALS). The process under development between the Company and Sandhill represents a step-change in the production of UDCA: it is expected to be lower in cost and will not rely on animal-sourced raw materials, unlike most current manufacturing of UDCA and other cholic acids.
Willow now expects that, upon completion of its development project with Sandhill and assuming the optimized enzyme is utilized in Sandhill's end-market manufacture, following receipt of milestone payments, it may receive a reasonably significant percent of Sandhill's end-market revenues. This royalty-bearing agreement would be more attractive than Willow originally expected and highlights the Company's rapid steps to bring in nearer term revenue.
"We are very pleased to have executed this agreement so quickly following our partnership with Sandhill and highly appreciate their collaborative work with us to create an alternative, more sustainable and less expensive source of UDCA to battle several significant health conditions in an era of escalating healthcare costs," said Dr. Chris Savile, Willow's President and CEO. "I am also proud of our R&D team's hard work and accomplishments to bring this commercial agreement to fruition, which further endorses our reputation in helping our partners sustainably solve their commercial challenges and in bringing cost-effective innovation to their end markets."
"We are delighted with Willow's rapid progress in successfully executing the development phases of this project. Our confidence in their results and the ensuing value has accelerated our decision to put in place a mutually rewarding commercial agreement," said J. Gregory Reid, Ph.D., Chief Scientific Officer of Sandhill. "We look forward to converting this value-added technology package into commercial reality and broadening the availability of sustainably sourced UDCA to support better health for people and our planet."